Chloroform Market to Reach USD 9.64 Billion by 2032 as Pharmaceutical and Agrochemical Demand Expands

The Chloroform Market is entering a period of steady expansion, supported by growing demand from pharmaceutical research, agrochemical manufacturing, chemical processing, and specialized industrial applications. According to the latest market assessment by Maximize Market Research, the Chloroform Market was valued at USD 7.87 billion in 2024 and is expected to grow at a CAGR of 2.56% from 2025 to 2032, reaching nearly USD 9.64 billion by 2032.

Market Estimation, Growth Drivers and Opportunities

Chloroform, also known as trichloromethane, remains an important chemical solvent and intermediate used across multiple industrial and scientific applications. Growth in pharmaceutical and biotechnology research is supporting demand because chloroform is used in laboratory procedures, including DNA and RNA research, extraction processes, and the preservation of biological materials. Its ability to dissolve a broad range of organic compounds also maintains its relevance in chemical and pharmaceutical applications.

The expanding agrochemical industry represents another important growth driver. Increasing agricultural production requirements and continuing research into pesticides and insecticides are creating opportunities for chloroform-based chemical processing. At the same time, demand from chemical manufacturing, refrigerant-related applications, and industrial processing contributes to market development.

However, environmental and health regulations remain important considerations. Restrictions associated with toxicological characteristics, environmental impacts, and controlled applications may limit consumption in certain markets. These regulatory pressures are also encouraging manufacturers to improve production efficiency, process safety, emissions management, and product stewardship. Consequently, opportunities are emerging for companies that can deliver high-purity products while improving manufacturing sustainability and regulatory compliance.

Receive a Free Sample Copy Instantly : https://www.maximizemarketresearch.com/request-sample/147197/ 

U.S. Market Trends and Investment Outlook

The United States remains an important market within North America because of its established pharmaceutical, chemical, laboratory, and industrial manufacturing base. During 2025, the U.S. chemical industry continued to focus on operational efficiency, sustainability, supply-chain resilience, and higher-value specialty chemical applications. Olin Corporation maintained its position as a major U.S. producer of chlorinated organics and continued emphasizing product stewardship, environmental management, and manufacturing efficiency. Another significant development involved Occidental's agreement in October 2025 to sell its OxyChem chemical business to Berkshire Hathaway for approximately USD 9.7 billion. OxyChem's portfolio includes chemicals serving pharmaceutical, healthcare, water-treatment, and industrial markets. Such corporate restructuring demonstrates the strategic value of established chemical assets and may influence future investment, production efficiency, and supply-chain strategies across the U.S. chlorinated chemicals industry.

Market Segmentation: Largest-Share Segments

By Application: The solvent segment held the largest revenue share in 2024. Chloroform's solvent properties make it valuable in chemical, biological, and pharmaceutical applications, particularly where organic compounds require specialized extraction or dissolution.

By End User: The agrochemical industry accounted for the largest revenue share in 2024. Increasing agricultural productivity requirements and the use of chloroform in pesticide and insecticide manufacturing support this segment's leading position.

Competitive Analysis

The competitive landscape includes established chemical manufacturers and specialized laboratory chemical suppliers. The following companies are among the prominent players identified in the market landscape:

Olin Corporation: Olin is a major U.S. producer of chlorinated organics and chlor-alkali products. Its focus on manufacturing efficiency, product stewardship, environmental management, and process optimization can support reliable supplies of chlorinated chemicals.

Merck & Co., Inc.: Merck's broad pharmaceutical and research ecosystem creates demand for high-quality laboratory and research chemicals. Continued expansion of pharmaceutical research and biotechnology activities supports the wider requirement for specialized chemical reagents and solvents.

Shin-Etsu Chemical Co., Ltd.: Shin-Etsu continues to invest in higher-value chemical and pharmaceutical-related businesses. In 2025, the company announced approximately JPY 10 billion of investment to strengthen its pharmaceutical cellulose operations in Japan and Germany, highlighting its focus on reliable specialty-chemical supply and advanced production capabilities.

Tokuyama Corporation: Tokuyama has been transforming its business portfolio toward higher-value electronics, healthcare, and advanced-material applications. In 2025, the company adopted industrial AI technology to improve manufacturing operations, maintenance, productivity, and safety. Such digitalization can strengthen chemical production efficiency and support more sophisticated manufacturing environments.

Tokyo Chemical Industry Co., Ltd.: TCI is a significant supplier of laboratory and research chemicals, supporting pharmaceutical, biotechnology, academic, and industrial research. Increasing demand for analytical and research-grade chemicals creates opportunities for specialized chloroform products.

Regional Analysis

United States: The U.S. benefits from strong pharmaceutical research, chemical manufacturing, biotechnology activity, and industrial infrastructure. Regulatory oversight encourages controlled handling and manufacturing practices while supporting investments in safer and more efficient processes.

China: China is an important growth market because of its expanding chemical manufacturing base, pharmaceutical research activity, industrial development, and increasing demand for HVAC and refrigeration-related applications.

Japan: Japan maintains a sophisticated chemical and pharmaceutical ecosystem supported by advanced manufacturing capabilities, research infrastructure, and investments in high-purity and specialty chemicals.

Germany: Germany remains a significant European chemical manufacturing center. Its established pharmaceutical and industrial sectors support demand for specialty solvents and chemical intermediates, while stringent environmental standards encourage process optimization and sustainable production.

Key Players

Key companies in the Chloroform Market include Olin Corporation, Merck & Co., Inc., Shin-Etsu Chemical Co., Ltd., Tokuyama Corporation, Tokyo Chemical Industry Co., Ltd., FUJIFILM Wako Pure Chemical Corporation, Sisco Research Laboratories Pvt. Ltd., Meghmani Finechem Limited, Henan GP Chemicals Co., Ltd., BASF SE, abcr GmbH, and Merck KGaA, among others.

Why This Market Matters Now

The Chloroform Market matters now because demand is increasingly connected to pharmaceutical research, agrochemical development, chemical manufacturing, and specialized laboratory applications. At the same time, regulatory requirements are reshaping how chlorinated chemicals are produced, handled, and utilized. Manufacturers that combine supply reliability, product purity, process efficiency, environmental responsibility, and technological innovation are positioned to address changing customer requirements. With the market projected to reach USD 9.64 billion by 2032, investment in efficient manufacturing and high-value applications will remain important to the industry's development.

Explore More Related Reports:

Global Strontium Carbonate Market https://www.maximizemarketresearch.com/market-report/global-strontium-carbonate-market/87780/

Polyether Polyols Market https://www.maximizemarketresearch.com/market-report/global-polyether-polyols-market/64035/

About Maximize Market Research

Maximize Market Research Pvt. Ltd. (MMR) is a global market research and consulting company that provides reliable, data-focused, and practical business insights. The firm serves a wide range of industries, including healthcare, pharmaceuticals, technology, automotive, electronics, chemicals, personal care, and consumer goods. Through market forecasts, competitive analysis, strategic consulting, and industry impact assessments, MMR helps organizations understand changing market conditions, identify growth opportunities, and make informed business decisions for long-term success.

Contact Us

Maximize Market Research Pvt. Ltd.
2nd Floor, Navale IT Park Phase 3
Pune Banglore Highway, Narhe
Pune, Maharashtra 411041, India
Phone: +91 9607365656
Email: sales@maximizemarketresearch.com